Isotretinoin and the controversy of psychiatric adverse effects

International Journal of Dermatology

Volumn 45, Issue 7, 2006, Pages 789-799

  Strahan, Jamison E ^a,b   Raimer, Sharon ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; ISOTRETINOIN; RETINOIC ACID; RETINOID; SEROTONIN;

ACNE; DEPRESSION; DISEASE EXACERBATION; DRUG DOSE REGIMEN; DRUG MECHANISM; DRUG METABOLISM; EVIDENCE BASED MEDICINE; HIPPOCAMPUS; HUMAN; INFORMATION PROCESSING; INSOMNIA; MANDATORY REPORTING; MEDLINE; MENTAL DISEASE; MOOD CHANGE; NEUROPHYSIOLOGY; PATHOGENESIS; POSTMARKETING SURVEILLANCE; PROSPECTIVE STUDY; PSYCHOSIS; RETROSPECTIVE STUDY; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SUICIDE; SUICIDE ATTEMPT; VIOLENCE;

ACNE VULGARIS; BRAIN; DERMATOLOGIC AGENTS; HUMANS; ISOTRETINOIN; MENTAL DISORDERS; RECEPTORS, RETINOIC ACID;

EID: 33745625649     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2006.02660.x     Document Type: Review

References (63)

1. Hazen PG, Carney JF, Walker AE, et al. Depression - a side effect of 13-cis-retinoic acid therapy. J Am Acad Dermatol 1983; 9: 278-279.
2. O'Donnell J. Overview of existing research and information linking isotretinoin (Accutane), depression, psychosis, and suicide. Am J Ther 2003; 10: 148-159.
3. Wysowski DK, Swann J, Vega A. Use of isotretinoin (Accutane) in the United States: Rapid increase from 1992 through 2000. J Am Acad Dermatol 2002; 46: 505-509.
4. Conlan MF. Suicide link: More FDA regulations, designed to protect patients, are coming for acne medication. Drug Topics 2001; 145: 49.
5. Hull PR, D'Arcy CD. Isotretinoin use and subsequent depression and suicide: Presenting the evidence. Am J Clin Dermatol 2000; 4: 493-505.
6. Goldsmith LA, Bolognia JL, Callen JP, et al. American Academy of Dermatology Consensus Conference on the safe and optimal use of isotretinoin: Summary and recommendations. J Am Acad Dermatol 2004; 50: 900-906.
7. Bremner JD. Does isotretinoin cause depression and suicide? Psychopharmacol Bull 2003; 37: 64-78.
8. Jacobs DG, Deutsch NL, Brewer M. Suicide, depression, and isotretinoin: is there a causal link? J Am Acad Dermatol 2001; 45: S168-S175.
9. Lindemayr H. Isotretinoin intoxication in attempted suicide. Acta Derm Venereol 1986; 66: 452-453.
10. Burket JM, Storrs FJ. Nodulocystic infantile acne occurring in a kindred of steatocystoma. Arch Dermatol 1987; 123: 432-433.
11. Villalobos D, Ellis M, Snodgrass WR. Isotretinoin (Accutane)-associated psychosis. Vet Hum Toxicol 1989; 31: 362.
12. Hepburn NC. Deliberate self-poisoning with isotretinoin. Br J Dermatol 1990; 122: 840-841.
13. Gatti S, Serri F. Acute depression from isotretinoin [letter]. J Am Acad Dermatol 1991; 25: 132.
14. Aubin S, Lorette G, Muller C, et al. Massive isotretinoin intoxication. Clin Exp Dermatol 1995; 20: 348-350.
15. Cotterill JA, Cunliffe WJ. Suicide in dermatological patients. Br J Dermatol 1997; 137: 246-250.
16. Cott AD, Wisner KL. Isotretinoin treatment of a woman with bipolar disorder. J Clin Psychiatry 1999; 60: 407-408.
17. Middelkoop T. RoAccutane (isotretinoin) and the risk of suicide: Case report and a review of the literature and pharmacovigilance reports. J Pharm Prac 1999; 12: 374-378.
18. Ng CH, Tamm MM, Hook SJ. Acne, isotretinoin treatment and depression. World J Biol Psychiatry 2001; 2: 159-161.
19. Meyskens FL. Short clinical reports. J Am Acad Dermatol 1982; 6: 732.
20. Bruno NP, Beacham BE, Burnett JW. Adverse effects of isotretinoin therapy. Cutis 1984; 33: 484-489.
21. Bigby M, Stern RS. Adverse reactions to isotretinoin: A report from the Adverse Drug Reaction Reporting System. J Am Acad Dermatol 1988; 18: 543-552.
22. Scheinman PL, Peck GL, Rubinow DR, et al. Acute depression from isotretinoin. J Am Acad Dermatol 1990; 22: 1112-1113.
23. Duke EE, Guenther L. Psychiatric reactions to the retinoids. Can J Dermatol 1993; 5: 467.
24. Bravard P, Krug M, Rzeznick JC. Isotretinoin and depression: Care is needed [letter] Nouv Dermatol 1993; 12: 215.
25. Byrne A, Costello M, Grcene E, Zibin T. Isotretinoin therapy and depression: Evidence for an association. Ir J Psych Med 1998; 15: 58-60.
26. Adverse Drug Reactions Advisory Committee. Depression with isotretinoin. Aust Adverse Drug Reaction Bull 1998; 17. Available online at URL: http://www.tga.gov.au/docs/html/aadrbltn/aadr9808.htm. Accessed on September 15, 2004.
27. Irish Medicines Board. RoAccutane. Drug Safety Newsletter, 7th edn. 1998. Available online at URL: http://www.imb.ie/uploads/publications/ 7077996_Issue%208pdf. Accessed on September 15, 2004.
28. Accutane/RoAccutane Action Group. Accutane/RoAccutane Action Group homepage [online]. Available from URL: http://www.roAccutaneaction.com/ index.htm. Accessed on September 15, 2004.
29. Wysowski DK, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol 2001; 45: 515-519.
30. Wooltorton E. Accutane (isotretinoin) and psychiatric adverse effects. CMAJ 2003; 168: 66.
31. Hull PR, Demkiw-Bartel C. Isotretinoin use in acne: Prospective evaluation of adverse events. J Cutan Med Surg 2000; 4: 66-70.
32. Jick SS, Kremers HM, Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol 2000; 136: 1231-1236.
33. Elias PM, Williams ML. Retinoids, cancer, and the skin. Arch Dermatol 1981; 117: 160-168.
34. Chen CC, Heller J. Uptake of retinol and retinoic acid from serum retinol-binding protein by retinal pigment epithelial cells. J Biol Chem 1977; 252: 5216-5221.
35. Ong DE, Chytil F. Specificity of cellular retinol-binding protein for compounds with vitamin A activity. Nature 1975; 255: 74-75.
36. Chytil F, Ong DE. Cellular retinol and retinoic acid-binding proteins in vitamin A action. Fed Proc 1979; 38: 2510-2518.
37. Johnson BC, Kennedy M, Chiba N. Vitamin A and nuclear RNA synthesis. Am J Clin Nutr 1969; 22: 1048-1058.
38. Mangelsdorf DJ, Kliewer SA, Kakizuka A, et al. Retinoid receptors. Recent Prog Horm Res 1993; 48: 99-121.
39. Sporn MB, Dunlop NM, Newton DL, et al. Relationships between structure and activity of retinoids. Nature 1976; 263: 110-113.
40. Farrell LW, Strauss JS, Stranieri AM. The treatment of sever cystic acne with 13-cis retinoic acid. Evaluation of sebum production and the clinical response in a multiple dose trial. J Am Acad Dermatol 1980; 3: 602.
41. Pochi PE, Strauss JS, Downing DT. Skin surface lipid composition, acne, pubertal development, and urinary excretion of testosterone and 17-ketosteroids in children. J Invest Dermatol 1977; 69: 485-489.
42. Strauss JS, Peck GL, Olsen TG. Sebum composition during oral 13-cis-retinoic acid administration. J Invest Dermatol 1978; 70: 228.
43. Tsukada M, Schroder M, Roos TC, et al. 13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors. J Invest Dermatol 2000; 115: 321-327.
44. McEvoy GK. Miscellaneous skin and mucous membrane agents: Isotretinoin. In: McEvoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, Inc., 2004: Ch. 84: 36.
45. Stahl SM. Depression and bipolar disorders. In: Essential Psychopharmacology: Neuroscientific Basis and Practical Application, 2nd edn. Cambridge: Cambridge University Press, 2002.
46. Nolte J. Drives, emotions, and memories: The hypothalamus and limbic systems. In: The Human Brain: An Introduction to its Functional Anatomy, 4th edn. St. Louis, MO: Mosby Inc., 1999.
47. Sapolsky RM. Depression, antidepressants, and the shrinking hippocampus. Proc Natl Acad Sci USA 2001; 98: 12,320-12,322.
48. Stahl SM. Psychosis and schizophrenia. In: Essential Psychopharmacology: Neuroscientific Basis and Practical Application, 2nd edn. Cambridge: Cambridge University Press, 2002.
49. Grippo AJ, Na ES, Johnson RF, et al. Sucrose ingestion elicits reduced Fos expression in the nucleus accumbens of anhedonic rats. Brain Res 2004; 1019: 259-264.
50. Sakai Y, Crandall JE, Brodsky J, et al. 13-cis retinoic acid (Accutane) suppresses hippocampal cell survival in mice. Ann NY Acad Sci 2004; 1021: 436-440.
51. Crandell J, Sakai Y, Zhang J, et al. 13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice. Proc Natl Acad Sci USA 2004; 101: 5111-5116.
52. Shors TJ, Miesagaes G, Beylin A, et al. Neurogenesis in the adult is involved in the formation of trace memories. Nature 2001; 410: 372-376.
53. Samad TA, Krezel W, Chambon P, et al. Regulation of dopaminergic pathways by retinoids: Activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family. Proc Natl Acad Sci USA 1997; 94: 14,349-14,354.
54. Goodman AB. Three independent lines of evidence suggest retinoids as causal to schizophrenia. Proc Natl Acad Sci USA 1998; 95: 7240-7244.
55. Zetterstrom RH, Solomin L, Jansson L, et al. Dopamine neuron agenesis in Nurr1-deficient mice. Science 1997; 276: 248-250.
56. Ruiz I, Altaba A, Jessell TM. Retinoic acid modifies the pattern of cell differentiation in the central nervous system of neurula stage Xenopus embryos. Development 1991; 112: 945-958.
57. Ito K, Morita T. Role of retinoic acid in mouse neural crest cell development in vitro. Dev Dyn 1995; 204: 211-218.
58. Pitts MR. Positive rechallenge cases of Accutane-associated depressive symptoms: Dermatologic and Ophthalmic Drugs Advisory Committee to the Food and Drug Administration, Gaithersburg (MD), 2000 [online] Available from URL: http://www.fda.gov/ohrms/dockets/ac/00/slides/3639s2i.pdf. Accessed on September 15, 2004.
59. Kovacs SO, Mallory SB. Mood changes associated with isotretinoin and substance abuse. Pediatr Dermatol 1996; 13: 350.
60. Brent DA, Baugher M, Bridge J, et al. Age- and sex-related risk factors for adolescent suicide. J Am Acad Child Adolesc Psychiatry 1999; 38: 1497-1505.
61. Beautrais AL. Suicide and serious suicide attempts in youth: A multiple-group comparison study. Am J Psychiatry 2003; 160: 1093-1099.
62. Schulpis K, Georgala S, Papakonstantinou ED, et al. Psychological and sympatho-adrenal status in patients with cystic acne. J Eur Acad Dermatol Venereol 1999; 13: 24-27.
63. Peck GL. Short clinical reports. J Am Acad Dermatol 1982; 6: 732-733.